News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Next Pharmaceuticals Discloses Results of Nexrutine(R) Clinical Study


11/29/2007 10:17:54 AM

SALINAS, Calif.--(BUSINESS WIRE)--Next Pharmaceuticals announced today the results of a clinical study on Nexrutine, conducted at The LaValle Metabolic Institute in Cincinnati, Ohio. Nexrutine is a proprietary blend of natural ingredients developed to address general aches and pains associated with physical activity and over-exertion. Out of the 401 participants 369 (92%) reported Nexrutine provided pain relief and 373 (93%) reported improvement in their overall condition. Three hundred sixty one (90%) reported Nexrutine helped provide a restful sleep.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES